El Butlletí de la Recerca es fa ressò de les publicacions indexades a la Web of Science i a Scopus, però també podeu fer-nos arribar les vostres publicacions a través de l’URecerca – Gestió de la Producció Científica que trobareu al Campus Virtual.
Current Trends and Future Directions in Urban Social Prescribing
Litt, J. S., Coll-Planas, L., Sachs, A. L., Masó Aguado, M., & Howarth, M. (2023). Current Trends and Future Directions … Read More
The artificial intelligence revolution in primary care: Challenges, dilemmas and opportunities
Vidal-Alaball, J., Panadés Zafra, R., Escalé-Besa, A., & Martinez-Millana, A. (2024). The artificial intelligence revolution in primary care: Challenges, dilemmas … Read More
A toolbox of machine learning software to support microbiome analysis
Marcos-Zambrano, L. J., López-Molina, V. M., Bakir-Gungor, B., Frohme, M., Karaduzovic-Hadziabdic, K., Klammsteiner, T., Ibrahimi, E., Lahti, L., Loncar-Turukalo, T., … Read More
Vagus nerve dysfunction in the post–COVID-19 condition: A pilot cross-sectional study
Lladós, G., Massanella, M., Coll-Fernández, R., Rodríguez, R., Hernández, E., Lucente, G., López, C., Loste, C., Santos, J. R., España-Cueto, … Read More
Trend and Joinpoint Analysis of Cancer Incidence and 1-Year Mortality in North-East Spain 2005–2020
Roura, P., Puigoriol, E., Altimiras, J., Batiste-Alentorn, E., & Roman Dégano, I. (2023). Trend and Joinpoint Analysis of Cancer Incidence … Read More
A cross-sectional study to ascertain malaria prevalence among asymptomatic travellers arriving on the Lihir Group of Islands, Papua New Guinea: implications for elimination efforts
Millat-Martínez, P., Baro, B., Kasian, B., Lorry, L., Sanz, S., Wali, C., . . . Mitjà, O., Bassat, Q. (2023). … Read More
What is bad for the heart is bad for the brain?
Sangüesa, G., Batlle, M., & Guasch, E. (2023). What is bad for the heart is bad for the brain? Heart … Read More
Diabetic microvascular disease in non-classical beds: The hidden impact beyond the retina, the kidney, and the peripheral nerves
Mauricio, D., Gratacòs, M., & Franch-Nadal, J. (2023). Diabetic microvascular disease in non-classical beds: The hidden impact beyond the retina, … Read More
Effect of Foot Orthoses on Angular Velocity of Feet
Florenciano Restoy, J. L., Solé-Casals, J., Borràs-Boix, X. (2023). Effect of Foot Orthoses on Angular Velocity of Feet. Sensors (Basel, … Read More
A Meta-Review to Guide Military Screening and Treatment of Gambling Problems
Segura, A., Heyman, R. E., Ochshorn, J., & Slep, A. M. S. (2023). A Meta-Review to Guide Military Screening and … Read More
STELLAR-303: A phase 3 study of XL092 in combination with atezolizumab versus regorafenib in patients with previously treated metastatic colorectal cancer (mCRC)
Hecht, J. R., Tabernero, J., Parikh, A. R., Wang, Y. J., Wang, Z., Schwickart, M., . . . Saeed, A. … Read More
Impact of Lynch syndrome, BRAFV600E, and RAS mutations on outcomes in MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Analysis of combined international cohorts
Colle, R., Lonardi, S., Cachanado, M., Overman, M. J., Elez, E., Fakih, M., . . . Andre, T. (2023). Impact … Read More
BREAKWATER safety lead-in (SLI): Encorafenib (E) plus cetuximab (C) plus chemotherapy for BRAFV600E metastatic colorectal cancer (mCRC)
Kopetz, S., Yoshino, T., Kim, T. W., Yaeger, R., Desai, J., Wasan, H. S., . . . Tabernero, J. (2023). … Read More
Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study
Tabernero, J., Prager, G. W., Fakih, M., Ciardiello, F., Van Cutsem, E., Elez, E., . . . Taieb, J. (2023). … Read More
Gene expression profiling in tumors with and without tertiary lymphoid structures across cancer-types
Solis, E. S., Pascual, T., Torres, E. S., Gonzalez-Farre, B., Brasó-Maristany, F., Farre, X. G., . . . Tabernero, J., … Read More
Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (mG/ GEJ) adenocarcinoma: Survival results from the phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study
Janjigian, Y. Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J. P., . . . Tabernero, J., Rha, … Read More
Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study
Janjigian, Y. Y., Al-Batran, S. E., Wainberg, Z. A., Van Cutsem, E., Molena, D., Muro, K., . . . Tabernero, … Read More
Identification and external validation of clinical-molecular features to predict benefit from oxaliplatin reintroduction/rechallenge in patients with refractory metastatic colorectal cancer (mCRC)
Salva, F., Paes, R., Silva, M. C. E., Cruz, H., Gonzalez, N. S., Baraibar, I., . . . Tabernero, J., … Read More